SAM
BIIB icon

Sentinel Asset Management’s Biogen BIIB Stock Holding History

Sentinel Asset Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-72,200
Closed -$22.6M – 16
2017
Q3 		$22.6M Sell
72,200
-2,100
-3% -$622K 0.54% 61
2017
Q2 		$20.2M Hold
74,300
– – 0.49% 78
2017
Q1 		$20.3M Sell
74,300
-11,400
-13% -$3.22M 0.48% 76
2016
Q4 		$24.3M Buy
85,700
+200
+0.2% +$59.3K 0.61% 61
2016
Q3 		$26.8M Buy
85,500
+20,250
+31% +$6M 0.64% 59
2016
Q2 		$15.8M Buy
65,250
+14,350
+28% +$3.78M 0.37% 91
2016
Q1 		$13.3M Buy
50,900
+18,000
+55% +$4.75M 0.3% 113
2015
Q4 		$10.1M Buy
+32,900
New +$9.45M 0.25% 122

Other funds holding BIIB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Sentinel Asset Management's BIIB Position: Q4 2017 in Review

Sentinel Asset Management sold out of Biogen (BIIB) in Q4 2017, closing a stake of 72,200 shares — an estimated $22.6M sold.

Sentinel Asset Management first reported a position in BIIB in Q4 2015 and held it in 8 quarters. The position peaked at $26.8M in Q3 2016. 1,123 funds tracked by Wall St. Rank hold BIIB as of Q4 2017.

  • Sentinel Asset Management reported no remaining Biogen position as of Q4 2017 after selling out during the quarter.
  • Sentinel Asset Management sold 72,200 Biogen shares in Q4 2017, an estimated $22.6M.
  • Sentinel Asset Management first reported a position in Biogen in Q4 2015 and held it in 8 quarters.
  • Sentinel Asset Management's Biogen position peaked at $26.8M in Q3 2016.
  • 1,123 funds tracked by Wall St. Rank held Biogen as of Q4 2017.

Based on Sentinel Asset Management's 13F filing for Q4 2017, filed 14 Feb 2018.